Lupin Limited has informed the Exchange regarding a press release dated February 17, 2023, titled "Lupin Receives EIR from U.S. FDA for its Injectable Facility in Nagpur.".
Lupin Limited has informed the Exchange regarding a press release dated February 17, 2023, titled "Lupin Receives EIR from U.S. FDA for its Injectable Facility in Nagpur.".